Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Rebecca Wilkes's Articles

Absolute Antibody Launches FleXpress™ High-Throughput Recombinant Antibody Production Service

Absolute Antibody launches FleXpress™ High-Throughput  Recombinant Antibody Production Service which enables the rapid production of large numbers of recombinant antibodies at 80 ml scale.
 

Invest in Newcastle: A Newcastle medtech company has secured nearly £250,000 in funding from Innovate UK to further its research into the impact of genetics on implants.

A Newcastle medtech company has secured nearly £250,000 in funding from Innovate UK to further its research into the impact of genetics on implants.

Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation

Inivata, a leader in liquid biopsy, is pleased to announce that Dr. Nitzan Rosenfeld, Co-founder and Chief Scientific Officer at Inivata has been announced the winner of the 2020 Pezcoller Foundation European Association for Cancer Research (EACR) Cancer Researcher Award.  

AMSBIO: Generation of Muscle Cells in 3 Easy Steps

AMSBIO offers a Skeletal Muscle Differentiation kit that enables you to differentiate human pluripotent stem cells to skeletal muscle myotubes with high yields, without cell sorting or genetic manipulation. Myotubes are contractile, express typical muscle markers that show striated sarcomeres.

Absolute Antibody Partners with the Technical University of Denmark  to Offer Antibodies against Animal Venom Toxins

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms.

Arctoris has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs.

Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs. BioTarget 2020 is now open for applications.

Domainex : LUNAC Therapeutics selects Domainex as its strategic drug discovery partner

Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies.

Discovery Park potential recognised by Govt Life Sciences Opportunity Zone status

Discovery Park, the thriving science park for  ambitious and growing life sciences companies, has been named a Life Sciences Opportunity Zone (LSOZ) by the UK Government’s Office for Life Sciences.

Imperial College Spinout Addressing UK Transplant Organ Shortage

A spin-out from Imperial College, Accunea has developed vital organ transplant technology that will make available more organs for transplant and reduce the numbers of deaths due to increasing waiting list times.

Fieldfisher advised on £34 million worth of venture capital deals in life sciences in 2019

European law firm, Fieldfisher advised on £34 million (€40.3 million) worth of venture capital deals in the life sciences sector, last year.

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.